Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth

Oncogene

Volumn 21, Issue 55, 2002, Pages 8498-8505

  Ling, Ming Tat ^a   Wang, Xianghong ^a   Ouyang, Xue Song ^a   Lee, Terence K W ^b   Fan, Tian Yong ^a   Xu, Kexin ^a   Tsao, Sai Wah ^a,b   Wong, Y C ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cell growth; Id 1; MAPK; Prostate cancer

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTISENSE OLIGONUCLEOTIDE; HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; TRANSCRIPTION FACTOR EGR 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SERUM; SIGNAL TRANSDUCTION;

EID: 0037028212     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206007     Document Type: Article

References (29)

1. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA and Munger K. (1999). Proc. Natl. Acad. Sci. USA, 96, 9637-9641.
2. Alani RM, Young AZ and Shifflett CB. (2001). Proc. Natl. Acad. Sci. USA, 98, 7812-7816.
3. Bain G, Cravatt CB, Loomans C, Alberola-Ila J, Hedrick SM and Murre C. (2001). Nature Immunol., 2, 165-171.
4. Benezra R, Rafii S and Lyden D. (2001). Oncogene, 20, 8334-8341.
5. Dudley DT, Pang L, Decker SJ, Bridges AJ and Saltiel AR. (1995). Proc. Natl. Acad. Sci. USA, 92, 7686-7689.
6. Eid MA, Kumar MV, Iczkowski KA, Bostwick DG and Tindall DJ. (1998). Cancer Res., 58, 2461-2468.
7. Fan M, Du L, Stone AA, Gilbert KM and Chambers TC. (2000). Cancer Res., 60, 6403-6407.
8. Gioeli D, Mandell JW, Petroni GR, Frierson Jr HF and Weber MJ. (1999). Cancer Res., 59, 279-284.
9. Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H and Oda K. (1994). J. Biol. Chem., 269, 2139-2145.
10. Benezra R, Davis RL, Lockshon D, Turner DL and Weintraub H. (1990). Cell, 61, 49-59.
11. Kawashita Y, Ohtsuru A, Kaneda Y, Nagayama Y, Kawazoe Y, Eguchi S, Kuroda H, Fujioka H, Ito M, Kanematsu T and Yamashita S. (1999). Hum. Gene Ther., 10, 1509-1519.
12. Kleeff J, Ishiwata T, Friess H, Buchler MW, Israel MA and Korc M. (1998). Cancer Res., 58, 3769-3772.
13. Langlands K, Down GA and Kealey T. (2000). Cancer Res., 60, 5929-5933.
14. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J and Desprez PY. (2000). Cancer Res., 60, 1332-1340.
15. Ling MT, Chan KW and Choo CK. (2001). J. Endocrinol., 170, 287-296.
16. Maruyama H, Kleeff J, Wildi S, Friess H, Buchler MW, Israel MA and Korc M. (1999). Am. J. Pathol., 155, 815-822.
17. Nickoloff BJ, Chaturvedi V, Bacon P, Qin JZ, Denning MF and Diaz MO. (2000). J. Biol. Chem., 275, 27501-27504.
18. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G and Hara E. (2001). Nature, 409, 1067-1070.
19. Olson EN and Klein WH. (1994). Genes Dev., 8, 1-8.
20. Ouyang XS, Wang X, Lee DT, Tsao SW and Wong YC. (2001). Carcinogenesis, 22, 965-973.
21. Ouyang XS, Wang X, Lee DT, Tsao SW and Wong YC. (2002a). J. Urol., 167, 2598-2602.
22. Ouyang XS, Wang X, Ling MT, Wong HL, Tsao SW and Wong YC. (2002b). Carcinogenesis, 23, 721-725.
23. Peverali FA, Ramqvist T, Saffrich R, Pepperkok R, Barone MV and Philipson L. (1994). EMBO J., 13, 4291-4301.
24. Polsky D, Young AZ, Busam KJ and Alani RM. (2001). Cancer Res., 61, 6008-6011.
25. Ristow HJ. (1996). Growth Regul., 6, 96-109.
26. Sakurai D, Yamaguchi A, Tsuchiya N, Yamamoto K and Tokunaga K. (2001). Biochem. Biophys. Res. Commun., 284, 436-442.
27. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B and Birner P. (2001). Cancer Res., 61, 5703-5706.
28. Tournay O and Benezra R. (1996). Mol. Cell. Biol., 16, 2418-2430.
29. Zebedee Z and Hara E. (2001). Oncogene, 20, 8317-8325.